FDA Yanks Voting Rights from Drug Safety Committee Member Who Opposes Bayer Birth Control Pill
Monday, December 12, 2011
For opposing the use of birth control pills made by Bayer, a consumer advocate has lost his voting power on a Food and Drug Administration (FDA) advisory panel.
Sid Wolfe, head the Public Citizen Health Research Group, was a full member of the FDA’s Drug Safety and Risk Management Advisory Committee until FDA officials stripped him of his ability to vote just before an upcoming review of Yaz and Yasmin, two of Bayer’s most popular pregnancy-control medications.
The FDA cited “intellectual conflict of interest” for its decision regarding Wolfe, whose group publicly warned women not to use the pills. Concerns have been raised about the linkage between blood clots and birth control pills, like Bayer’s, containing a hormone called drospirenone.
Bayer is being sued by thousands of who became ill or died as a result of taking the pills. Ed Silverman at the pharmaceutical industry blog, Pharmalot, says newly unsealed documents from the litigation reveal that former FDA commissioner David Kessler wrote “a scathing expert opinion” accusing the drugmaker of withholding safety information regarding its pills from regulators.
FDA Pulls Wolfe Off Panel Over ‘Intellectual’ Conflict (by Ed Silverman, Pharmalot)
Former FDA Commish: Bayer Hid Yasmin Data ((by Ed Silverman, Pharmalot)
- Top Stories
- Unusual News
- Where is the Money Going?
- U.S. and the World
- Appointments and Resignations
- Latest News
- Federal Judges Order Obama Administration to Release Memo Justifying Assassination of Americans
- Oklahoma Legislators, Bowing to Big Business, Raise Rates for Small Producers of Solar and Wind Power
- Cold War could Turn into Wet War if U.S. Navy Dolphins Deploy to Black Sea
- Sale of Post Office Properties Ignored Historical Importance
- Nebraskans Want Colorado to Share Cost of Prosecuting Citizens Caught with Marijuana in Nebraska